genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Wilson among Co-Founders of Gene Therapy Developer Launched with $115.5M
News
Cancer Cells May Have Achilles’ Heel in Cholesterol
News
Autism Severity Largely Linked to Hidden Part of the Human Genome
Artificial Intelligence
Artificial Intelligence Improves Ovarian Cancer Prognosis
News
CRISPR Toolbox Gains an Enhanced Cas12a for Genome Editing
Insights
Insights
Eyeing Epigenetics
Bioprocessing
Key Cell Culture Technology Trends
Bioprocessing
Sanofi Inks Bispecific Antibody Deal with Biomunex
Bioprocessing
Fujifilm to Build New U.K. Center of Excellence
Bioprocessing
SGS Expands Glasgow Facility’s Testing Capabilities
A-Lists
Insights
Unlucky 13: Top Clinical Trial Failures of 2018
February 2019 Vol. 39 No. 2
10 Takeover Targets to Watch in 2019
Insights
Top 10 Global Biopharma IPOs of 2018
A-Lists
5 Biopharma Trends to Watch in 2019
A-Lists
Top 10 RNA-Based Biopharmas of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Wilson among Co-Founders of Gene Therapy Developer Launched with $115.5M
Posters
High-intensity UV LEDs for Point of Use Production of RNase-free Water
News
Cancer Cells May Have Achilles’ Heel in Cholesterol
Posters
High-throughput Gene Expression Analysis of 3D Airway Organoids
Magazine
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
January 2019 Vol. 39 No. 1
CRISPR’s China Crisis
January 2019 Vol. 39 No. 1
PATH: New Organization Fostering AI, Automation and Healthcare
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Posters
High-intensity UV LEDs for Point of Use Production of RNase-free Water
Posters
High-throughput Gene Expression Analysis of 3D Airway Organoids
Webinars
Better by Design: Single-Cell Characterization for Enhanced Cell Therapies
Webinars
Biology by Design: Applying Gigabases of DNA to Bioengineering
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
Therapeutics
Autoimmune Disease Drugs
Autoimmune Disease Drugs
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Autoimmune Disease Drugs
argenx Plans Autoimmune Treatments Using Halozyme’s ENHANZE Drug-Delivery Technology
Autoimmune Disease Drugs
Top 10 GEN News Articles of 2018
Autoimmune Disease Drugs
Lilly, Aduro to Develop STING Pathway Inhibitors for Autoimmune Diseases
Autoimmune Disease Drugs
Microbiome Modeling Reveals How Bacteria Shape Host Fitness
Autoimmune Disease Drugs
New Work Opens Door to Manipulating Aberrant Calcium Signaling in Immune System
Autoimmune Disease Drugs
GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development
Autoimmune Disease Drugs
Merck & Co. Partners with Sutro on Cytokine Derivatives for Cancer,...
Autoimmune Disease Drugs
Pollution and Genes Work Together to Increase Severity of Rheumatoid Arthritis
Autoimmune Disease Drugs
Cell Therapy Developer Rubius Therapeutics Raises $100M More
Autoimmune Disease Drugs
With $250M in Financing, AstraZeneca Spinout to Focus on Severe Autoimmune...
Autoimmune Disease Drugs
Testosterone-Activated Anti-MS Mechanism Could Protect Women
Autoimmune Disease Drugs
Immune Disorder Trigger Identified
Autoimmune Disease Drugs
Technique Converts Harmful Autoantibodies into Anti-Inflammatory Antibodies In Vivo
Autoimmune Disease Drugs
Evolutionary Backtrack Offers Up Novel Rheumatoid Arthritis Candidate
Autoimmune Disease Drugs
First Xontogeny Startup Landos Raises $10M to Develop Autoimmune Disease Drugs
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![GlaxoSmithKline (GSK) has made a $300 million equity investment in 23andMe under a collaboration designed to accelerate development of new therapies for both companies by using genetic data to identify new drug targets. [Source: © fotoliaxrender/Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug5_2014_56448122_DNAblue_NovelDiagnosticGenomic12114111424-324x160.jpg "GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development")
![Individuals with a particular version of a gene have an increased risk for rheumatoid arthritis and the severity of bone damage. [National Library of Medicine]](https://www.genengnews.com/wp-content/uploads/2018/08/Apr19_2018_NLM_RheumatoidArthritis2477013519-324x160.jpg "Pollution and Genes Work Together to Increase Severity of Rheumatoid Arthritis")
![This confocal microscopic image of a healthy mouse T cell uses color florescence to illustrate how the protein Gimap5 (upper-right faint green area) and the enzyme GSK3 (red) overlap in small structures called vesicles inside cells (colocalized yellow area). This happens before GSK3 enters the cell nucleus (shown in blue). This step is important to limit DNA damage in active T cells during their expansion. The image is part of a study published Jan. 30 by Nature Communications from researchers at Cincinnati Children's. [Cincinnati Children's]](https://www.genengnews.com/wp-content/uploads/2018/08/Jan30_2018_CincinnatiChildrens_TCellRegulator1019210011-324x160.jpg "Immune Disorder Trigger Identified")
